|
6/3/2013 9:00:18 AM
|
|
|
5/29/2013 7:00:27 AM
|
|
|
5/28/2013 4:17:06 PM
|
NPS Pharma Announces Exercise Of Over-Allotment Option And Closing Of Public Offering
|
|
5/21/2013 5:58:59 PM
|
NPS Pharma Prices Public Offering Of 6 Mln Common Stock
|
|
5/20/2013 4:52:56 PM
|
|
|
5/20/2013 4:21:41 PM
|
NPS Pharmaceuticals Commences Public Offering Of 6 Mln Shares Of Its Common Stock
|
|
5/9/2013 8:10:10 AM
|
NPS Pharmaceuticals Q1 Loss/Shr $0.09 Vs. Loss $0.12 Last Year
|
|
5/9/2013 7:30:29 AM
|
|
|
3/20/2013 7:51:11 AM
|
|
|
3/19/2013 9:59:46 AM
|
|
|
3/19/2013 9:03:29 AM
|
|
|
3/19/2013 6:06:10 AM
|
|
|
3/19/2013 2:03:16 AM
|
NPS Pharma And Takeda Says NPS Regains Full Worldwide Rights To Teduglutide, Recombinant Human Parathyroid Hormone 1-84
|
|
3/13/2013 10:16:18 AM
|
|
|
2/26/2013 9:00:21 AM
|
|
|
2/21/2013 5:05:11 PM
|
NPS Pharma Posts Q4 Loss Per Share Of $0.14 Vs. Loss $0.10 Year Ago
|
|
2/14/2013 7:03:24 AM
|
|
|
2/11/2013 9:32:07 AM
|
|
|
1/9/2013 11:03:59 AM
|
|
|
12/27/2012 9:38:37 PM
|
|